Position in JNJ
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$3,924,344
+$220,834 QoQ
Shares Held
15,452
+2.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.84%
of 13F equity value
Holder Rank
#1,788
of 4,676 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Legacy Financial Advisors, Inc. holds $18,531,940 across 8 Drug Manufacturers - General names. JNJ ranks #2 (21.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,438 | $4,123,640 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
15,452 | $3,924,344 | |
| 3 | MRK |
Merck & Co., Inc.
|
28,939 | $3,718,661 | |
| 4 | ABBV |
AbbVie Inc.
|
9,983 | $2,512,122 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
26,235 | $1,511,660 | |
| 6 | AMGN |
Amgen Inc
|
3,407 | $1,233,742 | |
| 7 | PFE |
Pfizer Inc
|
34,409 | $828,568 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
5,376 | $679,203 |
All Filings in JNJ
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,924,344 | 15,452 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $3,703,510 | 15,151 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $2,976,561 | 14,383 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $2,692,298 | 14,520 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,976,432 | 12,939 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $3,033,876 | 18,294 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,305,821 | 15,944 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,915,621 | 17,991 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,331,252 | 15,950 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $2,794,268 | 17,664 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $2,435,896 | 15,541 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $2,673,604 | 17,166 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,694,665 | 16,280 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $2,181,160 | 14,072 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $3,012,059 | 17,051 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $2,284,426 | 13,984 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $2,509,458 | 14,137 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $2,405,542 | 13,573 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $2,228,871 | 13,029 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $1,979,182 | 12,255 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $1,877,706 | 11,398 | Shares | Sole | 2021-07-21 | |
| 2021-03-31 | $1,868,495 | 11,369 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $1,485,352 | 9,438 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $1,378,479 | 9,259 | Shares | Sole | 2020-11-09 | |
| No filing history on record for this holder in this stock. | ||||||